PLA2G7 and diabetes mellitus: The higher CAS prevalence in non-MASLD patients likely reflects their older age and greater cumulative burden of traditional risk factors, underscoring the importance of interpreting Lp-PLA2 within the context of both metabolic liver disease and the overall stage of diabetes.